Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Permanyer
2022-07-01
|
| 叢編: | Gaceta Mexicana de Oncología |
| 主題: | |
| 在線閱讀: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|